(1S,2R)-2-Phenylcyclopropylamine - CAS 3721-28-6

Catalog:	BB023228
Product Name:	(1S,2R)-2-Phenylcyclopropylamine
CAS:	3721-28-6
Synonyms:	(1S,2R)-2-phenyl-1-cyclopropanamine; (1S,2R)-2-phenylcyclopropan-1-amine

Technical Data

Patents

Literatures

Computed Properties

IUPAC Name:	(1S,2R)-2-phenylcyclopropan-1-amine
Description:	(1S,2R)-2-Phenylcyclopropylamine (CAS# 3721-28-6) is a useful research chemical.
Molecular Weight:	133.19
Molecular Formula:	C9H11N
Canonical SMILES:	C1C(C1N)C2=CC=CC=C2
InChI:	InChI=1S/C9H11N/c10-9-6-8(9)7-4-2-1-3-5-7/h1-5,8-9H,6,10H2/t8-,9+/m1/s1
InChI Key:	AELCINSCMGFISI-BDAKNGLRSA-N
Boiling Point:	218.3 °C at 760 mmHg
Melting Point:	164-166 °C /Hydrochloride/
Solubility:	Sol in water /Sulfate/
Appearance:	Liquid
LogP:	2.20150
Stability:	Stable in light, Heat & in air /sulfate/

Publication Number	Title	Priority Date
CN-111944034-A	Stable polypeptide inhibitor derived from SNAIL1 based on LSD1 substrate and application thereof	20200818
US-2020360523-A1	Anti-cancer nuclear hormone receptor-targeting compounds	20190514
WO-2020232119-A1	Anti-cancer nuclear hormone receptor-targeting compounds	20190514
WO-2020163816-A1	Quinolin-4-one and 4(1h)-cinnolinone compounds and methods of using same	20190208
EP-3617181-A1	Synthesis of trans-2-phenylcyclopropylamine or a salt or solvate thereof	20180830

PMID	Publication Date	Title	Journal
33034194	20201210	Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1)	Journal of medicinal chemistry
26599973	20160122	Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class	Toxicology letters
22859721	20121101	In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamine	Molecular pharmacology
22985508	20121018	Risperidone attenuates the increase of extracellular nitric oxide and glutamate levels in serotonin syndrome animal models	Neuroscience letters
23048001	20121009	Tianeptine in combination with monoamine oxidase inhibitors for major depressive disorder	BMJ case reports

Related Products

Online Inquiry

Name:

* Phone:

* Service & Products of Interested:

Project Description:

* Quantity:

* Email:

* Verification Code:

Customer Support

If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?

Submit Requirement

Customer Centered

Global Delivery

Warehouses in multiple cities to ensure fast delivery

Quality Assurance

Strict process parameter control to ensure product quality

Large Stock

> 20,000 building blocks and intermediates from stock

Process Scale-up

Process scale-up from lab to industrial scale

Flexible Batch Size

Flexible batch size for diverse industrial demands

Related Functional Groups

Amines and Anilines

[1158353-54-8]
(4-Pyrazol-1-ylphenyl)methanamine sulfuric acid
[1006473-17-1]
[(2,3-Difluorophenyl)methyl][(1,3-dimethylpyrazol-4-yl)methyl]amine
[1820736-42-2]
1-{4-[3-(Trifluoromethyl)-1H-pyrazol-1-yl]phenyl}methanamine hydrochloride
[932890-93-2]
1-{4-[(2,4-Dichlorobenzyl)oxy]-3-ethoxyphenyl}methanamine
[1250876-38-0]
1-Cyclopentyl-1H-pyrazole-3,5-diamine
[1824357-78-9]
2-(1-Benzyl-3-pyrazolyl)ethylamine

Complexity:	116
Compound Is Canonicalized:	Yes
Covalently-Bonded Unit Count:	1
Defined Atom Stereocenter Count:	2
Defined Bond Stereocenter Count:	0
Exact Mass:	133.089149355
Formal Charge:	0
Heavy Atom Count:	10
Hydrogen Bond Acceptor Count:	1
Hydrogen Bond Donor Count:	1
Isotope Atom Count:	0
Monoisotopic Mass:	133.089149355
Rotatable Bond Count:	1
Topological Polar Surface Area:	26
Undefined Atom Stereocenter Count:	0
Undefined Bond Stereocenter Count:	0
XLogP3:	1.5